載入...
Targeting insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) in metastatic melanoma to increase efficacy of BRAF(V600E) inhibitors
Melanoma is one of the deadliest forms of skin cancer. Although BRAF inhibitors significantly enhance survival of metastatic melanoma patients, most patients relapse after less than a year of treatment. We previously reported that mRNA binding protein Insulin-like growth factor 2 mRNA-binding protei...
Na minha lista:
| 發表在: | Mol Carcinog |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6408214/ https://ncbi.nlm.nih.gov/pubmed/29369405 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mc.22786 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|